NEO
NeoGenomics IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$1.45B
P/E Ratio
—
EPS
$-0.77
Beta
1.81
52W High
$13.74
52W Low
$4.72
50-Day MA
$9.10
200-Day MA
$9.94
Dividend Yield
—
Profit Margin
-13.30%
Forward P/E
222.22
PEG Ratio
2.09
About NeoGenomics Inc
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
Fundamentals
| Revenue (TTM) | $745.97M |
| Gross Profit (TTM) | $321.51M |
| EBITDA | $4.27M |
| Operating Margin | -9.34% |
| Return on Equity | -11.60% |
| Return on Assets | -2.64% |
| Revenue/Share (TTM) | $5.80 |
| Book Value | $6.49 |
| Price-to-Book | 1.80 |
| Price-to-Sales (TTM) | 1.95 |
| EV/Revenue | 2.354 |
| EV/EBITDA | -27.92 |
| Quarterly Earnings Growth (YoY) | 130.60% |
| Quarterly Revenue Growth (YoY) | 11.10% |
| Shares Outstanding | $130.21M |
| Float | $118.21M |
| % Insiders | 2.06% |
| % Institutions | 108.39% |
Historical Volatility
HV 10-Day
69.39%
HV 20-Day
56.46%
HV 30-Day
55.32%
HV 60-Day
54.17%
HV Rank
70.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($15.06 target)
2
Strong Buy6
Buy4
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026